Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.05 USD
-0.09 (-7.89%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $1.06 +0.01 (0.95%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.05 USD
-0.09 (-7.89%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $1.06 +0.01 (0.95%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Zacks News
Top Ranked Value Stocks to Buy for February 22nd
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 22nd:
Top Ranked Value Stocks to Buy for February 21st
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 21st:
Top Ranked Value Stocks to Buy for February 16th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 16th:
Top Ranked Value Stocks to Buy for February 14th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 14th:
Aceto (ACET) is Oversold: Can It Recover?
by Zacks Equity Research
Aceto Corporation (ACET) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Top Ranked Value Stocks to Buy for February 9th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 9th:
Top Ranked Value Stocks to Buy for February 7th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 7th:
Top Ranked Value Stocks to Buy for February 6th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 6th:
Top Ranked Value Stocks to Buy for February 3rd
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 3rd:
Falling Earnings Estimates Signal Weakness Ahead for Eagle Pharmaceuticals (EGRX)
by Zacks Equity Research
Eagle Pharmaceuticals (EGRX) should not be considered as it holds an unfavorable Zacks Rank and it has seen negative earnings estimate revisions.
Top Ranked Value Stocks to Buy for January 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 25th:
5 Affordable Stocks with Impressive Returns
by Zacks Equity Research
5 Affordable Stocks with Impressive Returns
4 Stocks Flaunting Low Price-to-Cash-Flow Ratio
by Zacks Equity Research
In value investing, investors pick stocks that are cheap but fundamentally sound.
McKesson (MCK) to Pay $150 Million to Department of Justice
by Zacks Equity Research
McKesson (MCK) has finalized to resolve U.S. Drug Enforcement Administration and Department of Justice potential federal civil and administrative claims.
Luxottica Group (LUX) Jumps: Stock Adds 8.2% in Session
by Zacks Equity Research
Luxottica Group S.p.A. (LUX) shares rose over 8% in the last trading session.
Will Aceto (ACET) Be a Suitable Pick for Value Investors?
by Zacks Equity Research
Let's see Aceto (ACET) stock to find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.